Squamous Cell Lung Carcinoma Clinical Trials

Find Squamous Cell Lung Carcinoma Clinical Trials Near You

A First-in-Human, Open-label, Multicenter, Phase 1 Study of EPI-326 in Patients With Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma

Status: Recruiting
Location: See all (8) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or metastatic HNSCC and to patients with any documented EGFR-mutant locally advanced or metastatic NSCLC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participant has a life expectancy \> 12 weeks at Day 1.

• Participant has an ECOG performance status of 0-2.

• Participant has pathologically confirmed NSCLC or HNSCC.

• o For NSCLC: the tumor harbors any documented EGFR mutation, insertion, or deletion.

• Participant has locally advanced or metastatic NSCLC or HNSCC.

• Participant has adequate organ function

Locations
United States
California
Site 105 - START Los Angeles
RECRUITING
Los Angeles
New Jersey
Site 104 - START New Jersey
RECRUITING
East Brunswick
New York
Site 107 - START New York - Long Island
RECRUITING
Lake Success
Tennessee
Sarah Cannon and HCA Research Institute
RECRUITING
Nashville
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Site 102 - START San Antonio
RECRUITING
San Antonio
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
RECRUITING
Kaohsiung City
Contact Information
Primary
EpiBiologics Clinical Trials
clinicaltrials@epibiologics.com
650-955-7486
Time Frame
Start Date: 2026-03-31
Estimated Completion Date: 2029-07
Participants
Target number of participants: 110
Treatments
Experimental: EPI-326
Experimental: Dose Escalation
Sponsors
Leads: EpiBiologics

This content was sourced from clinicaltrials.gov

Similar Clinical Trials